ROIV
Price
$11.39
Change
-$0.21 (-1.81%)
Updated
Jun 27 closing price
Capitalization
7.74B
50 days until earnings call
VRNA
Price
$93.82
Change
-$0.58 (-0.61%)
Updated
Jun 27 closing price
Capitalization
7.99B
32 days until earnings call
Interact to see
Advertisement

ROIV vs VRNA

Header iconROIV vs VRNA Comparison
Open Charts ROIV vs VRNABanner chart's image
Roivant Sciences
Price$11.39
Change-$0.21 (-1.81%)
Volume$11.13M
Capitalization7.74B
Verona Pharma
Price$93.82
Change-$0.58 (-0.61%)
Volume$951.42K
Capitalization7.99B
ROIV vs VRNA Comparison Chart in %
Loading...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ROIV vs. VRNA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROIV is a Buy and VRNA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ROIV: $11.39 vs. VRNA: $93.82)
Brand notoriety: ROIV and VRNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ROIV: 182% vs. VRNA: 67%
Market capitalization -- ROIV: $7.74B vs. VRNA: $7.99B
ROIV [@Biotechnology] is valued at $7.74B. VRNA’s [@Biotechnology] market capitalization is $7.99B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ROIV’s FA Score shows that 0 FA rating(s) are green whileVRNA’s FA Score has 1 green FA rating(s).

  • ROIV’s FA Score: 0 green, 5 red.
  • VRNA’s FA Score: 1 green, 4 red.
According to our system of comparison, VRNA is a better buy in the long-term than ROIV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ROIV’s TA Score shows that 3 TA indicator(s) are bullish while VRNA’s TA Score has 2 bullish TA indicator(s).

  • ROIV’s TA Score: 3 bullish, 4 bearish.
  • VRNA’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than VRNA.

Price Growth

ROIV (@Biotechnology) experienced а -0.52% price change this week, while VRNA (@Biotechnology) price change was -0.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ROIV is expected to report earnings on Aug 18, 2025.

VRNA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRNA($7.99B) and ROIV($7.74B) have the same market capitalization . VRNA YTD gains are higher at: 102.024 vs. ROIV (-3.719). VRNA has higher annual earnings (EBITDA): -121.41M vs. ROIV (-1.1B). ROIV has more cash in the bank: 4.89B vs. VRNA (401M). ROIV has less debt than VRNA: ROIV (100M) vs VRNA (244M). VRNA has higher revenues than ROIV: VRNA (119M) vs ROIV (29.1M).
ROIVVRNAROIV / VRNA
Capitalization7.74B7.99B97%
EBITDA-1.1B-121.41M906%
Gain YTD-3.719102.024-4%
P/E Ratio1.97N/A-
Revenue29.1M119M24%
Total Cash4.89B401M1,219%
Total Debt100M244M41%
FUNDAMENTALS RATINGS
VRNA: Fundamental Ratings
VRNA
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
2
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ROIVVRNA
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
73%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
71%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
Bearish Trend 14 days ago
73%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CWEB39.970.37
+0.93%
Direxion Dly CSI CHN Itnet Bull 2X Shrs
GAST28.94N/A
N/A
Gabelli Automation ETF
LCDS56.58N/A
N/A
JPMorgan Fundamental Data Sci Lg Cor ETF
IBTI22.34-0.01
-0.07%
iShares iBonds Dec 2028 Term Treasury ETF
MGOV20.07-0.05
-0.25%
First Trust Intermediate Gvt Opps ETF

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-1.81%
IMVT - ROIV
62%
Loosely correlated
N/A
ACLX - ROIV
52%
Loosely correlated
+0.90%
CRNX - ROIV
51%
Loosely correlated
-0.10%
KRYS - ROIV
51%
Loosely correlated
-2.60%
CGON - ROIV
50%
Loosely correlated
-0.46%
More

VRNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRNA has been loosely correlated with TERN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VRNA jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRNA
1D Price
Change %
VRNA100%
-0.61%
TERN - VRNA
40%
Loosely correlated
-4.25%
ARCT - VRNA
40%
Loosely correlated
-7.49%
ROIV - VRNA
39%
Loosely correlated
-1.81%
CRNX - VRNA
39%
Loosely correlated
-0.10%
LGND - VRNA
39%
Loosely correlated
-1.33%
More